| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/18/2002 | CN1370146A Alpha/Beta integrin inhibitors |
| 09/18/2002 | CN1369283A Eye drops containing bio-active catalytic enzyme |
| 09/17/2002 | US6452052 Such as bis-(2-(3-hydroxy-butyrylamido)phenyl)-disulfide; treating allergies of the eyes, nose, skin, ear, gastrointestinal tract, airways or lung and preventing/ treating systemic mastocytosis |
| 09/17/2002 | US6452044 Benzenedicarboxylic acid derivatives |
| 09/17/2002 | US6452001 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451858 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 09/17/2002 | US6451834 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 09/17/2002 | US6451794 2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2187908C Non-splicing variants of gp350/220 |
| 09/17/2002 | CA2020431C Aqueous liquid eyedrop composition |
| 09/16/2002 | CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070461A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/12/2002 | WO2002070459A1 Novel amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070455A1 Malic acid addition salts of terbinafine |
| 09/12/2002 | WO2002070008A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | WO2002069998A1 Regulating vegf expression by a protein of the tis11 family |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2002026717A3 Hydroxy acid integrin antagonists |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2002003990A3 Use of substituted insole compounds for treating excessive intraocular pressure |
| 09/12/2002 | WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists |
| 09/12/2002 | WO2001091770A3 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | US20020128527 Use in medicine, pharmacy, biology and technology, friction-reducing additives in engines |
| 09/12/2002 | US20020128512 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering |
| 09/12/2002 | US20020128483 Sulfonamide-containing indole compounds |
| 09/12/2002 | US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/12/2002 | US20020128480 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 09/12/2002 | US20020128471 Useful for treating cellular hyperproliferation |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128304 Administering as anticarcinogenic agent |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128291 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome |
| 09/12/2002 | US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 09/12/2002 | US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone |
| 09/12/2002 | US20020128265 CRF receptor antagonists and methods relating thereto |
| 09/12/2002 | US20020128240 Treatment of hyperproliferative diseases using active vitamin D analogues |
| 09/12/2002 | US20020128225 Methods and products related to pulmonary delivery of polysaccharides |
| 09/12/2002 | US20020128224 Administering a nucleoside 5'-pyrophosphate pyranoside or analogue, of given formula |
| 09/12/2002 | US20020128191 Topical administration of ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein to reduce hyperemia, chemosis, mucous discharge, neovascularization or ulcer formation |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders |
| 09/12/2002 | US20020127558 Genetic polymorphism of MxA protein and use thereof |
| 09/12/2002 | US20020127281 Stabilized hyrogen peroxide solutions |
| 09/12/2002 | US20020127250 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | CA2440642A1 Dimeric isoflavones |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439939A1 Novel aminodicarboxylic acid derivatives |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439647A1 Side-chain-halogenated aminodicarboxylic acid derivatives as medicaments for treatment of cardiovascular disorders |
| 09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | CA2437592A1 Malic acid addition salts of terbinafine |
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1239033A1 Semaphorin receptor |
| 09/11/2002 | EP1238674A2 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237889A1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 09/11/2002 | EP1237886A1 Heterocyclic derivatives |
| 09/11/2002 | EP1237877A2 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 09/11/2002 | EP1237549A1 Lipoxin a4 and its analogs for the treatment of dry eye |
| 09/11/2002 | EP0910399B1 Stable pharmaceutical composition of bdnf |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368969A Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 09/11/2002 | CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/11/2002 | CN1368950A Novel aminobenzophenones |
| 09/11/2002 | CN1368889A Ocular tension lowering composition for topical admistration |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368247A Nano medicine 'Fuming' and its preparing process |
| 09/11/2002 | CN1368199A Nano medicine for treating deafness and its preparing process |
| 09/11/2002 | CN1368088A Nano medicine 'Mingjing Dihuang' and its preparing process |